Xortx Therapeutics Inc. (XRTX)
Market Open
31 Aug, 08:00 PM
TSX-V 
CA$
3. 19
0
0%
CA$
- Market Cap
- P/E Ratio
- Div Yield
880 Volume
- Eps
CA$ 3.19
Previous Close Want to track XRTX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Xortx Therapeutics Inc. (XRTX) Statistics
Valuation metrics
Market Cap -
Enterprise value -369.3K
Trailing P/E (ttm) -0.31
Forward P/E -
PEG ratio -0.01
Price/Sales (ttm) -
Price/Book (mrq) 0.66
Enterprise Value/Revenue -
Enterprise Value/EBITDA 0.1
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 556
Average volume (90 days) 352
Price summary
52-Week low 2.42
52-Week high 9.85
Beta -
50-Day moving average 3.04
200-Day moving average 3.1
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:5
Last split Date 27 Mar 2026
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -
Operating margin -
Operational effectiveness
Return on assets -0.6%
Return on equity -1.27%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -2.28
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 0.61
Total debt (mrq) -
Total Debt/Equity (mrq) 0.01
Current ratio (mrq) 3.59%
Book value per share (mrq) 3.4
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
2026 © Marketlog. All Rights Reserved.
